Picture of Vitrolife AB logo

VITR — Vitrolife AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Vitrolife tops STOXX as EBITDA more than doubles

** Shares of Vitrolife  VITR.ST  rise ~10% after the Swedish
medical technology group's Q2 EBITDA more than doubles to SEK
273 million  urn:newsml:reuters.com:*:nFWN2YW0XF
    ** VITR jumps to the top of the STOXX  .STOXX  index 
    ** "Vitrolife continues to improve organic growth and
margins with good balance support from all regions and both
technology and consumables," Redeye analyst Johan Unnerus says
    ** Unnerus adds that the improved gross margins in Q2 are
"essential after a softer period"
    ** Stock down 51.6% so far this year




 (Reporting by Jacob Rasmussen)
 ((jacob.rasmussen@thomsonreuters.com))

Recent news on Vitrolife AB

See all news